drug

macupatide

1 story · latest Aug 14, 2026

Status: Investigational
Code: LY3532226
Trials: 4 registered trials in coverage

Relationships

Developed by Eli Lilly

Timeline

Lilly posts orforglipron Phase 3 results; adds new early-phase studies

Aug 14Weekly roundup, 6 itemsbaricitinib brenipatide

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.